Stock Track | Parabilis Medicines Soars 66.75% Intraday on Successful IPO Pricing Above Expectations

Stock Track

Yesterday

Shares of Parabilis Medicines (PBLS) soared 66.75% during intraday trading on Wednesday, following its debut on the Nasdaq Global Select Market.

The significant surge is attributed to the company's successful initial public offering, which was priced above expectations. Parabilis Medicines priced its upsized IPO at $20 per share, above its anticipated range of $17 to $19, raising approximately $670 million. In a concurrent private placement, collaboration partner Regeneron Pharmaceuticals agreed to purchase shares for $75 million.

The offering was increased to 33.5 million shares from an initially planned 25 million, reflecting strong investor interest in the clinical-stage biopharmaceutical company as it commenced public trading.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1139874515"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1139874515\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1139874515?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-11 00:46","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1139874515","market":"hk","top_or_hot":-1,"title":"Stock Track | Parabilis Medicines Soars 66.75% Intraday on Successful IPO Pricing Above Expectations","media":"Stock Track","content":"<p>Shares of Parabilis Medicines (PBLS) soared 66.75% during intraday trading on Wednesday, following its debut on the Nasdaq Global Select Market.</p><p>The significant surge is attributed to the company's successful initial public offering, which was priced above expectations. Parabilis Medicines priced its upsized IPO at $20 per share, above its anticipated range of $17 to $19, raising approximately $670 million. In a concurrent private placement, collaboration partner Regeneron Pharmaceuticals agreed to purchase shares for $75 million.</p><p>The offering was increased to 33.5 million shares from an initially planned 25 million, reflecting strong investor interest in the clinical-stage biopharmaceutical company as it commenced public trading.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Parabilis Medicines Soars 66.75% Intraday on Successful IPO Pricing Above Expectations</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Parabilis Medicines Soars 66.75% Intraday on Successful IPO Pricing Above Expectations\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-06-11 00:46</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of Parabilis Medicines (PBLS) soared 66.75% during intraday trading on Wednesday, following its debut on the Nasdaq Global Select Market.</p><p>The significant surge is attributed to the company's successful initial public offering, which was priced above expectations. Parabilis Medicines priced its upsized IPO at $20 per share, above its anticipated range of $17 to $19, raising approximately $670 million. In a concurrent private placement, collaboration partner Regeneron Pharmaceuticals agreed to purchase shares for $75 million.</p><p>The offering was increased to 33.5 million shares from an initially planned 25 million, reflecting strong investor interest in the clinical-stage biopharmaceutical company as it commenced public trading.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PBLS","symbol_name":"Parabilis Medicines","start_time":0,"source_url":"","article_id":"1139874515","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1139874515","pubTimestamp":1781110004,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of Parabilis Medicines (PBLS) soared 66.75% during intraday trading on Wednesday, following its debut on the Nasdaq Global Select Market.The significant surge is attributed to the company's...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"PBLS":"Parabilis Medicines"},"translate_title":"个股追踪|Parabilis Medicines盘中大涨66.75%成功IPO定价超预期","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PBLS":1},"content_text":"Shares of Parabilis Medicines (PBLS) soared 66.75% during intraday trading on Wednesday, following its debut on the Nasdaq Global Select Market.The significant surge is attributed to the company's successful initial public offering, which was priced above expectations. Parabilis Medicines priced its upsized IPO at $20 per share, above its anticipated range of $17 to $19, raising approximately $670 million. In a concurrent private placement, collaboration partner Regeneron Pharmaceuticals agreed to purchase shares for $75 million.The offering was increased to 33.5 million shares from an initially planned 25 million, reflecting strong investor interest in the clinical-stage biopharmaceutical company as it commenced public trading.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}